The Human ACE2/TMPRSS2 Stable Cell Line is designed to express both the ACE2 and TMPRSS2 (transmembrane protease, serine 2) genes. TMPRSS2 is a serine protease that has been shown to facilitate the entry of SARS-CoV-2 into host cells by cleaving the viral spike protein, enhancing the binding of the virus to ACE2.
The HEK293T cell line, a derivative of HEK293, is chosen for its high transfection efficiency and ability to express high levels of recombinant proteins. When engineered to express both ACE2 and TMPRSS2, this cell line provides a robust model for studying the molecular interactions involved in SARS-CoV-2 entry and for evaluating potential antiviral strategies targeting these proteins.
A crucial component was found to be LRRC15, a TLR-related cell surface receptor, by whole-genome CRISPR activation screening. LRRC15 expression is elevated in lung myofibroblasts during severe COVID-19 infection and increases SARS-CoV-2 spike binding. While LRRC15 does not directly promote viral infection, it can inhibit the expression of antiviral factors, decrease collagen synthesis, and dampen SARS-CoV-2 infection in fibroblasts. According to this study, LRRC15 is a new spike-binding receptor for SARS-CoV-2 that is essential for regulating antiviral and antifibrotic responses as well as viral load management.
Figure 1. The researchers generated HEK293T-ACE2 stable cell lines by transducing HEK293T cells with an ACE2-expressing lentivirus, followed by immunostaining and single-cell sorting. They then transduced HEK293T-ACE2 cells with TMPRSS2-expressing lentivirus to create HEK293T-ACE2-TMPRSS2 clones, selecting a highly permissive clone for further experiments. Then, the researchers utilized HEK293T-ACE2-TMPRSS2 cells to confirm LRRC15 binding to SARS-CoV-2 spike protein via flow cytometry and immunoprecipitation, demonstrating interaction between LRRC15-GFP and spike protein, and showing LRRC15's role in viral binding and entry. (Loo L, et al., 2023)
The Human ACE2/TMPRSS2 Stable Cell Line - HEK293T is a cell line that co-expresses both the ACE2 and TMPRSS2 genes, which are crucial for the entry of SARS-CoV-2 into host cells. This cell line is a valuable tool for studying the molecular mechanisms of viral entry and for the development of antiviral strategies.
(1) Viral Entry Mechanism Studies:
The co-expression of ACE2 and TMPRSS2 in this cell line allows researchers to study the detailed process of viral entry, including the role of TMPRSS2 in facilitating SARS-CoV-2 spike protein priming. This knowledge is critical for understanding how the virus gains entry into cells and for identifying potential points of intervention to block viral entry.
(2)Antiviral Drug Screening:
The cell line is an excellent platform for high-throughput screening of compounds that could inhibit viral entry. By testing a vast array of molecules for their ability to prevent the interaction between the virus and its receptors, researchers can identify lead compounds for the development of new antiviral drugs.
(3)Vaccine Development:
In the context of vaccine development, this cell line can be used to evaluate the ability of candidate vaccines to prevent viral entry. By measuring the level of neutralizing antibodies produced in response to vaccination, researchers can assess the potential efficacy of vaccines in preventing SARS-CoV-2 infection.
Customer Q&As
How can the Human ACE2/TMPRSS2 Stable Cell Line - HEK293T be utilized to study the synergistic effects of ACE2 and TMPRSS2 in the context of SARS-CoV-2 infection and host cell response?
A: The cell line co-expresses both ACE2 and TMPRSS2, which are essential for SARS-CoV-2 entry into host cells. By studying the interactions between these two proteins, researchers can gain insights into the coordinated host cell response to viral infection and identify potential targets for therapeutic intervention.
What are the implications of using the Human ACE2/TMPRSS2 Stable Cell Line - HEK293T for the development of vaccines and vaccine adjuvants that enhance immune responses against SARS-CoV-2?
A: The cell line can be used to test the ability of candidate vaccines and adjuvants to prevent SARS-CoV-2 entry into host cells. By evaluating the immune response elicited by these candidates, researchers can optimize vaccine formulations to enhance protection against the virus.
How can researchers use the Human ACE2/TMPRSS2 Stable Cell Line - HEK293T to develop vaccines against SARS-CoV-2?
A: The cell line can be employed in vaccine development by testing the ability of candidate vaccines to prevent viral entry and replication. By evaluating the immune response elicited by these vaccines, researchers can optimize their formulation and delivery methods to enhance protection against SARS-CoV-2.
What are the potential applications of the Mouse Slc7a9/Slc3a1 Stable Cell Line - HEK293 in the field of systems biology, particularly for mapping the interactions between amino acid transport and other cellular components?
A: This cell line can be used in high-throughput screening assays to identify compounds that effectively inhibit SARS-CoV-2 entry or block the interaction between the virus and its human receptors. It allows for the rapid evaluation of drug candidates and their potential side effects on human cells.
How does the Human ACE2/TMPRSS2 Stable Cell Line - HEK293T contribute to the understanding of host-virus interactions beyond SARS-CoV-2?
A: The cell line can be adapted to study interactions with other coronaviruses or pathogens that use similar host receptors for entry. This can provide insights into the broader mechanisms of viral pathogenesis and inform the development of broad-spectrum antiviral strategies.
Ask a Question
Customer Reviews
High Transfection Efficiency
The Human ACE2/TMPRSS2 Stable Cell Line - HEK293T features high transfection efficiency, meaning it can effectively take up and express foreign genetic material. This characteristic is crucial for research requiring gene overexpression or knockout, as it ensures consistent and reliable experimental results across various applications, particularly in studying viral entry mechanisms.
United Kingdom
09/11/2023
Robust ACE2 and TMPRSS2 Expression
This cell line consistently expresses the ACE2 receptor and TMPRSS2 protease, pivotal for SARS-CoV-2 studies. The robust expression levels in Human ACE2/TMPRSS2 Stable Cell Line - HEK293T facilitate detailed investigations into the virus-host interactions and can accelerate the development of therapeutic strategies targeting these proteins.
Versatile Research Applications
Human ACE2/TMPRSS2 Stable Cell Line - HEK293T is versatile, suitable for a wide range of research applications, including virology, toxicology, and pharmacology. This versatility stems from the cell line's robust handling and maintenance characteristics, allowing us to use it in diverse experimental setups.
Detailed Documentation and Support
Accompanying the Human ACE2/TMPRSS2 Stable Cell Line - HEK293T is comprehensive documentation and technical support. This support ensures that we can maximize the utility of the cell line, addressing both routine and complex experimental scenarios with expert guidance.
Write a Review